CK8-24614-29107
2 vaccinations
8 coded responses
21 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 773 / TX
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Registered in v-safe
-
2021-02-20
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Survey response — day 0, dose 1MedDRA: Headache — Feeling: Good · HeadacheFree text: Slight headache, minimized by eating and hydrating afterwardMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
-
2021-02-26
Survey response — days 1–6 daily, dose 1MedDRA: Abdominal pain upper, Blood pressure increased, Decreased appetite, Fatigue, Headache, Nausea, Vertigo positional — Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Yesterday (2/25/21) awoke with severe positional vertigo, accompanying nausea, elevated BP, headache, tiredness, low appetite and later epigastric pain. This has continued.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Survey response — day 7, dose 1MedDRA: Dizziness, Fatigue — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Condition improved since yesterday. No vertigo as such, just lightheaded. Only slight headache and occ. queasiness. Fatigue is the principal symptomMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-13
Dose 2 — Pfizer-BioNTech
- 2021-03-13
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Asthenia, Decreased appetite, Nausea — Feeling: Fair · Site: Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Low appetite, queasy, weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal discomfort, Decreased appetite, Injection site discomfort, Injection site pain — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Decreased appetite; GI sensitivity. Tenderness, discomfort at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Gastrointestinal disorder — Feeling: Fair · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Decreased appetite, GI sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Injection site pain — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lingering slight soreness at site; slightly lightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-20
Survey response — day 7, dose 2MedDRA: Fatigue — Feeling: Good · Fatigue or tirednessFree text: A little tired - not up to my usual energy level but better than yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-06-14
- 2021-09-11
- 2022-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Pfizer-BioNTech | |
| 2 | 2021-03-13 | Pfizer-BioNTech |
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Slight headache, minimized by eating and hydrating afterward
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Yesterday (2/25/21) awoke with severe positional vertigo, accompanying nausea, elevated BP, headache, tiredness, low appetite and later epigastric pain. This has continued.
Release 4 — day 7, dose 1
Systemic reaction (other): Condition improved since yesterday. No vertigo as such, just lightheaded. Only slight headache and occ. queasiness. Fatigue is the principal symptom
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Low appetite, queasy, weakness
Systemic reaction (other): Decreased appetite; GI sensitivity. Tenderness, discomfort at injection site
Systemic reaction (other): Decreased appetite, GI sensitivity
Systemic reaction (other): Lingering slight soreness at site; slightly lightheaded
Release 6 — day 7, dose 2
Systemic reaction (other): A little tired - not up to my usual energy level but better than yesterday
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Abdominal discomfort | ✓ | ✓ | ✓ |
| SRO | Abdominal pain upper | ✓ | ✓ | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Blood pressure increased | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Vertigo positional | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release